Latest Breaking News On - Lexicon pharmaceuticals inc - Page 1 : comparemela.com

Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Free Report) was upgraded by StockNews.com to a “sell” rating in a research report issued on Thursday. Several other analysts have also commented on LXRX. Leerink Partnrs reiterated an “outperform” rating on shares of Lexicon Pharmaceuticals in a report on Tuesday, April 30th. Needham & Company LLC reissued a “hold” […]

Leerink partnrsLexicon pharmaceuticals incPrincipal securities incSwiss national bankChina universal asset management coNews ratings for lexicon pharmaceuticals dailyVictory capital management incInstitutional investors weigh in on lexicon pharmaceuticalsLexicon pharmaceuticals stock downLexicon pharmaceuticalsNeedham companyGet free reportPharmaceuticals stock downNational bankUniversal asset managementCapital management